Rare diseases
Investigational molecules
Locations
Ottiliavej 9, 2500, Denmark
H. Lundbeck A/S is strongly focused on migraine care, with research spanning chronic migraine, episodic migraine, paediatric migraine, and medication overuse headache. Its studies also address preventive treatment needs in both adults and younger populations.
The sponsor’s clinical portfolio includes interest in reducing migraine frequency and supporting long-term management across age groups.
H. Lundbeck A/S runs clinical trials in conditions such as Migraine, Parkinson's disease, Multiple system atrophy, Endocrine ophthalmopathy, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Study of Eptinezumab Given Intravenously for Prevention of Chronic Migraine in Adolescents Aged 12-17 Years
ItalyLong-term safety study of eptinezumab given by intravenous infusion for children and adolescents aged 6-17 years with chronic or episodic migraine
ItalyA Randomized Trial of lu af28996 dh1 to Reduce Motor Fluctuations in Adults with Parkinson’s Disease
CzechiaStudy on Lu AG09222 for Preventing Migraines in Adults Unresponsive to Previous Treatments
BulgariaStudy of Amlenetug for Patients with Multiple System Atrophy
FranceStudy of Lu AG22515 for Adults with Moderate-to-Severe Thyroid Eye Disease
BulgariaStudy of Eptinezumab as Add-on Treatment for Prevention of Migraine in Adults with Both Migraine and Medication Overuse Headache
DenmarkStudy on Eptinezumab for Preventing Chronic Migraine in Adults
PolandStudy of Lu AG13909 in Adults with Cushing's Disease to Evaluate Safety and Effectiveness
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
